ObsEva (NASDAQ:OBSV) Coverage Initiated by Analysts at StockNews.com

Equities researchers at StockNews.com assumed coverage on shares of ObsEva (NASDAQ:OBSV) in a research note issued on Thursday. The brokerage set a “hold” rating on the stock.

ObsEva Stock Performance

ObsEva has a 1 year low of $0.08 and a 1 year high of $2.14. The firm has a market capitalization of $7.94 million, a price-to-earnings ratio of -0.11 and a beta of 0.68. The company has a 50-day moving average price of $0.01.

ObsEva Company Profile

ObsEva SA is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic treatments for women’s reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. The company was founded by Ernest Loumaye and André Chollet on November 14, 2012 and is headquartered in Geneva, Switzerland.